Genome-wide expression profiling of patients with primary open angle glaucoma

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 9, 2012, Pages 5899-5904

  Colak, Dilek ^a   Morales, Jose ^b   Bosley, Thomas M ^c   Al Bakheet, Albandary ^a   AlYounes, Banan ^a   Kaya, Namik ^a   Abu Amero, Khaled K ^c,d  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; MALE; MICROARRAY ANALYSIS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENETICS; LEUKOCYTE; METABOLISM; METHODOLOGY; MIDDLE AGED; SAUDI ARABIA; UPREGULATION;

ADULT; AGED; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; GLAUCOMA, OPEN-ANGLE; HUMANS; LEUKOCYTES; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SAUDI ARABIA; UP-REGULATION;

EID: 84873031361     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9634     Document Type: Article

References (44)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Spaeth GL. A new classification of glaucoma including focal glaucoma. Surv Ophthalmol. 1994;(suppl 38):S9-S17.
3. Allingham RR, Liu Y, Rhee DJ. The genetics of primary openangle glaucoma: a review. Exp Eye Res. 2009;88:837-844.
4. Liu Y, Allingham RR. Molecular genetics in glaucoma. Exp Eye Res. 2011;93:331-339.
5. Thorleifsson G, Walters GB, Hewitt AW, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nature Genetics. 2010;42:906-909.
6. Burdon KP, Macgregor S, Hewitt AW, et al. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nature Genetics. 2011;43:574-578.
7. Juran BD, Lazaridis KN. Genomics in the post-GWAS era. Semin Liver Dis. 2011;31:215-222.
8. Kurian SM, Le-Niculescu H, Patel SD, et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry. 2011;16:37-58.
9. Saris CG, Horvath S, van Vught PW, et al. Weighted gene coexpression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics. 2009; 10:405.
10. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:261-268.
11. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol. 2005;62:210-215.
12. Kaya N, Colak D, Albakheet A, et al. A novel X-linked disorder with developmental delay and autistic features. Ann Neurol. 2012;71:498-508.
13. Abu-Amero KK, Hellani A, Gonzalez AM, Larruga JM, Cabrera VM, Underhill PA. Saudi Arabian Y-Chromosome diversity and its relationship with nearby regions. BMC Genetics. 2009;10: 59.
14. Bosley TM, Hellani A, Spaeth GL, et al. Down-regulation of OPA1 in patients with primary open angle glaucoma. Mol Vis. 2011;17:1074-1079.
15. Hu VW, Nguyen A, Kim KS, et al. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PloS one. 2009;4:e5775.
16. Takahashi M, Hayashi H, Watanabe Y, et al. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res. 2010; 119:210-218.
17. Abu-Amero KK, Larruga JM, Cabrera VM, Gonzalez AM. Mitochondrial DNA structure in the Arabian Peninsula. BMC Evol Biol. 2008;8:45.
18. Morrissey SP, Borruat FX, Miller DH, et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry. 1995;58:70-74.
19. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
20. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811-818.
21. Colak D, Kaya N, Al-Zahrani J, et al. Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics. 2009;94:20-31.
22. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34:374.
23. Huang DW, Sherman BT, Tan Q, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35:W169-W175.
24. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70.
25. Du J, Fu C, Sretavan DW. Eph/ephrin signaling as a potential therapeutic target after central nervous system injury. Curr Pharm Des. 2007;13:2507-2518.
26. Fu CT, Sretavan D. Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma. Invest Ophthalmol Vis Sci. 2012;53:76-84.
27. Filosa A, Paixao S, Honsek SD, et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci. 2009;12:1285-1292.
28. Du J, Tran T, Fu C, Sretavan DW. Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss. Invest Ophthalmol Vis Sci. 2007;48:5567-5581.
29. Dudek EJ, Lampi KJ, Lampi JA, et al. Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to sitespecific substrate deamidation. Invest Ophthalmol Vis Sci. 2010;51:4164-4173.
30. Zhang X, Dudek EJ, Liu B, et al. Degradation of C-terminal truncated alpha A-crystallins by the ubiquitin-proteasome pathway. Invest Ophthalmol Vis Sci. 2007;48:4200-4208.
31. Shen X, Ying H, Qiu Y, et al. Processing of optineurin in neuronal cells. J Biol Chem. 2011;286:3618-3629.
32. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary openangle glaucoma caused by mutations in optineurin. Science. 2002;295:1077-1079.
33. Neufeld AH, Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist. 2003;9:485-495.
34. Shazly TA, Aljajeh M, Latina MA. Autoimmune basis of glaucoma. Semin Ophthalmol. 2011;26:278-281.
35. Wang DY, Ray A, Rodgers K, et al. Global gene expression changes in rat retinal ganglion cells in experimental glaucoma. Invest Ophthalmol Vis Sci. 2010;51:4084-4095.
36. Davis LK, Meyer KJ, Schindler EI, et al. Copy number variations and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2011;52:7122-7133.
37. Fuchshofer R, Stephan DA, Russell P, Tamm ER. Gene expression profiling of TGFbeta2-and/or BMP7-treated trabecular meshwork cells: identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. Exp Eye Res. 2009;88:1020-1032.
38. Zhou Y, Pernet V, Hauswirth WW, Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther. 2005;12:402-412.
39. Bosley TM, Hellani A, Spaeth GL, et al. Down-regulation of OPA1 in patients with primary open angle glaucoma. Mol Vis. 2011;17:1074-1079.
40. Abu-Amero KK, Jaber M, Hellani A, Bosley TM. Genome-wide expression profile of LHON patients with the 11778 mutation. Br J Ophthalmol. 2010;94:256-259.
41. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27:622-647.
42. Barbacioru CC, Wang Y, Canales RD, et al. Effect of various normalization methods on Applied Biosystems expression array system data. BMC Bioinformatics. 2006;7:533.
43. Srlie T, Wang Y, Xiao C, et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics. 2006;7:127.
44. Walker SJ, Wang Y, Grant KA, Chan F, Hellmann GM. Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates. J Neurosci Methods. 2006; 152:179-189.